Indian Army Procures Essential Injectable Drugs and Pharmaceuticals

The Department of Military Affairs, under the Ministry of Defence, represented by the Indian Army, is hereby issuing a tender (Bid Number: GEM/2026/B/8151411) for the procurement of essential Drugs and Pharmaceuticals Products. This procurement, scheduled to commence on October 13, 2026, at 11:18 AM and conclude on October 23, 2026, at 12:00 PM, addresses a critical need for a diverse range of injectable medications. The Bill of Quantities (BOQ) specifically includes Dexmedetomidine (100 mcg/ml, 50 ml vial), Ondansetron (2 mg/ml, 4 ml Inj), Adenosine (3 mg/ml, 2 ml Inj), Vitamin B1 (50 mg Inj), Hyoscine Bromide (20 mg/ml, 1 ml Inj), a Multi-Vitamin Injection (IV, 2 to 10 ml with B1 30 mg, B6 30 mg, B12 300 mcg/ml), Amiodarone HCl (150 mg, 3 ml Inj), and Ketamine HCl (50 mg/ml, 2 ml Inj). A total quantity of 1485 units of these pharmaceuticals is required to support the operational and medical requirements of the Indian Army. Interested and qualified suppliers are invited to submit their bids for this vital tender.